(Q54113704)

24 May 2018

title

Targeting the tumor vasculature with combretastatin A-4 disodium phosphate: effects on radiation therapy. (English)

1 reference

24 May 2018

Adaptive radiation therapy

main subject

0 references

author name string

Li L

series ordinal

1

1 reference

24 May 2018

Rojiani A

series ordinal

2

1 reference

24 May 2018

Siemann DW

series ordinal

3

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 November 1998

1 reference

24 May 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

24 May 2018

volume

42

1 reference

24 May 2018

issue

4

1 reference

24 May 2018

page(s)

899-903

1 reference

24 May 2018

Angiogenesis in the pathobiology and treatment of vascular and malignant diseases.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900320-4

7 January 2021

Endothelial proliferation in tumours and normal tissues: Continuous labelling studies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900320-4

7 January 2021

Angiogenesis as a target for tumor treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900320-4

7 January 2021

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900320-4

7 January 2021

Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900320-4

7 January 2021

Anti-vascular approaches to solid tumour therapy: evaluation of vinblastine and flavone acetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900320-4

7 January 2021

Antineoplastic agents, 122. Constituents of Combretum caffrum

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900320-4

7 January 2021

Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900320-4

7 January 2021

Podophyllotoxin, steganacin and combretastatin: natural products that bind at the colchicine site of tubulin

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900320-4

7 January 2021

In vitro evaluation of the antineoplastic activity of combretastatin A-4, a natural product from Combretum caffrum (arid shrub).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900320-4

7 January 2021

An in vitro assay to measure the viability of KHT tumor cells not previously exposed to culture conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900320-4

7 January 2021

Recovery of cell subpopulations from human tumour xenografts following dissociation with different enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900320-4

7 January 2021

Chemosensitization of CCNU in KHT murine tumor cells in vivo and in vitro by the agent RB 6145 and its isomer PD 144872

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900320-4

7 January 2021

Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900320-4

7 January 2021

Radiobiological hypoxia in the KHT sarcoma: predictions using the Eppendorf histograph

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900320-4

7 January 2021

10.1016/S0360-3016(98)00320-4

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018